Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 22, 2026
Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc
04:01pm, Friday, 19'th Dec 2025
Exploring the Fund's Recent Portfolio Adjustments Vanguard Health Care Fund (Trades, Portfolio) recently submitted its N-PORT filing for the third quarter of 2
Bamco Inc. NY Boosts Stock Holdings in Exact Sciences Corporation $EXAS
03:56am, Saturday, 13'th Dec 2025
Bamco Inc. NY grew its holdings in Exact Sciences Corporation (NASDAQ: EXAS) by 26.4% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The institutional i
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the first clinical study results from its Oncodetect®
First Trust Advisors LP Trims Stake in Exact Sciences Corporation $EXAS
04:42am, Wednesday, 10'th Dec 2025
First Trust Advisors LP cut its position in shares of Exact Sciences Corporation (NASDAQ: EXAS) by 2.5% in the second quarter, according to the company in its most recent filing with the Securities an
Baird Financial Group Inc. Sells 30,218 Shares of Exact Sciences Corporation $EXAS
03:26am, Monday, 08'th Dec 2025
Baird Financial Group Inc. reduced its holdings in shares of Exact Sciences Corporation (NASDAQ: EXAS) by 9.7% during the second quarter, according to its most recent Form 13F filing with the Securiti
Fisher Asset Management LLC Sells 27,925 Shares of Exact Sciences Corporation $EXAS
04:40am, Thursday, 04'th Dec 2025
Fisher Asset Management LLC trimmed its position in Exact Sciences Corporation (NASDAQ: EXAS) by 15.0% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 1
Why Is Exact Sciences (EXAS) Up 45.4% Since Last Earnings Report?
12:31pm, Wednesday, 03'rd Dec 2025
Exact Sciences (EXAS) reported earnings 30 days ago. What's next for the stock?
Top 2 Health Care Stocks You May Want To Dump This Month
09:01am, Tuesday, 02'nd Dec 2025
As of Dec. 2, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Advisors Asset Management Inc. Cuts Position in Exact Sciences Corporation $EXAS
03:16am, Monday, 01'st Dec 2025
Advisors Asset Management Inc. reduced its stake in shares of Exact Sciences Corporation (NASDAQ: EXAS) by 31.4% during the undefined quarter, according to its most recent 13F filing with the SEC. The
This Top Dividend King Just Became an Even Better Buy
02:05am, Sunday, 30'th Nov 2025
Abbott Laboratories is acquiring Exact Sciences, in a move that will help bolster its diagnostics business. Abbott should expand the reach of Exact Sciences' key products and fuel its innovative engin
Exact Sciences Corporation (NASDAQ:EXAS) Given Consensus Recommendation of “Hold” by Analysts
01:39am, Saturday, 29'th Nov 2025
Exact Sciences Corporation (NASDAQ: EXAS - Get Free Report) has been given an average recommendation of "Hold" by the twenty-six research firms that are covering the stock, MarketBeat reports. One inv
Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights
12:41pm, Friday, 28'th Nov 2025
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
HAPPY THANKSGIVING AND ALERT: The M&A Class Action Firm Continues to Investigate the Merger – EXAS, SEE, CDTX, and MRSN
06:14pm, Thursday, 27'th Nov 2025
NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- We wish you a Happy Thanksgiving and Class Action Attorney Juan Monteverde with Monteverde and Associates PC (the "M&A Class Action Firm"), who has recovere
Halper Sadeh LLC Encourages GDOT, BLFY, EXAS Shareholders to Contact the Firm to Discuss Their Rights
01:33am, Tuesday, 25'th Nov 2025
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, will present 10 abstracts across its Precision Oncology portfolio at t
